ID   FM3A EM6-TG cl.13
AC   CVCL_VI65
SY   EM6-TG cl.13; EMS-induced 6-TG resistant clone 13
DR   Wikidata; Q93555081
RX   PubMed=230835;
RX   PubMed=1170081;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VI64 ! FM3A H-5
SX   Female
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
RX   PubMed=230835; DOI=10.1016/0006-291X(79)92005-9;
RA   Tsai Y.-J., Hanaoka F., Nakano M.M., Yamada M.-a.;
RT   "A mammalian DNA- mutant decreasing nuclear DNA polymerase alpha
RT   activity at nonpermissive temperature.";
RL   Biochem. Biophys. Res. Commun. 91:1190-1195(1979).
//
RX   PubMed=1170081; DOI=10.1016/0014-4827(75)90441-3;
RA   Sekiguchi T., Sekiguchi F., Tomii S.;
RT   "Genetic complementation in hybrid cells derived from mutagen-induced
RT   mouse clones deficient in HGPRT activity.";
RL   Exp. Cell Res. 93:207-218(1975).
//